167 related articles for article (PubMed ID: 10850542)
1. Implication of screening for FMR1 and FMR2 gene mutation in individuals with nonspecific mental retardation in Taiwan.
Tzeng CC; Tzeng PY; Sun HS; Chen RM; Lin SJ
Diagn Mol Pathol; 2000 Jun; 9(2):75-80. PubMed ID: 10850542
[TBL] [Abstract][Full Text] [Related]
2. An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome.
Tzeng CC; Lin SJ; Chen YJ; Kuo PL; Jong YJ; Tsai LP; Chen RM
Diagn Mol Pathol; 2001 Mar; 10(1):34-40. PubMed ID: 11277393
[TBL] [Abstract][Full Text] [Related]
3. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population.
Sharma D; Gupta M; Thelma BK
Genet Epidemiol; 2001 Jan; 20(1):129-144. PubMed ID: 11119302
[TBL] [Abstract][Full Text] [Related]
4. Screening for FMR1 and FMR2 mutations in 222 individuals from Spanish special schools: identification of a case of FRAXE-associated mental retardation.
Milà M; Sànchez A; Badenas C; Brun C; Jiménez D; Villa MP; Castellví-Bel S; Estivill X
Hum Genet; 1997 Oct; 100(5-6):503-7. PubMed ID: 9341861
[TBL] [Abstract][Full Text] [Related]
5. FMR2 expression in families with FRAXE mental retardation.
Gécz J; Oostra BA; Hockey A; Carbonell P; Turner G; Haan EA; Sutherland GR; Mulley JC
Hum Mol Genet; 1997 Mar; 6(3):435-41. PubMed ID: 9147647
[TBL] [Abstract][Full Text] [Related]
6. Pilot fragile X screening in normal population of Taiwan.
Tzeng CC; Cho WC; Kuo PL; Chen RM
Diagn Mol Pathol; 1999 Sep; 8(3):152-6. PubMed ID: 10565687
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of blood spot PCR in large-scale screening of fragile X syndrome in southern Taiwan.
Chow JC; Chen DJ; Lin CN; Chiu CY; Huang CB; Chiu PC; Lin CH; Lin SJ; Tzeng CC
J Formos Med Assoc; 2003 Jan; 102(1):12-6. PubMed ID: 12684606
[TBL] [Abstract][Full Text] [Related]
8. FRAXE mutation in mentally retarded patients using the OxE18 probe.
Mulatinho MV; Llerena JC; Pimentel MM
Int J Mol Med; 2000 Jan; 5(1):67-9. PubMed ID: 10601577
[TBL] [Abstract][Full Text] [Related]
9. Instability of the FMR2 trinucleotide repeat region associated with expanded FMR1 alleles.
Brown TC; Tarleton JC; Go RC; Longshore JW; Descartes M
Am J Med Genet; 1997 Dec; 73(4):447-55. PubMed ID: 9415473
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype.
Tzeng CC; Tsai LP; Hwu WL; Lin SJ; Chao MC; Jong YJ; Chu SY; Chao WC; Lu CL
Am J Med Genet A; 2005 Feb; 133A(1):37-43. PubMed ID: 15637705
[TBL] [Abstract][Full Text] [Related]
11. Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability.
Patsalis PC; Sismani C; Hettinger JA; Boumba I; Georgiou I; Stylianidou G; Anastasiadou V; Koukoulli R; Pagoulatos G; Syrrou M
Am J Med Genet; 1999 May; 84(3):184-90. PubMed ID: 10331587
[TBL] [Abstract][Full Text] [Related]
12. Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation.
Pandey UB; Phadke S; Mittal B
Genet Test; 2002; 6(4):335-9. PubMed ID: 12537661
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the fragile X syndrome in Yugoslav patients with non-specific mental retardation.
Major T; Culjkovic B; Stojkovic O; Gucscekic M; Lakic A; Romac S
J Neurogenet; 2003; 17(2-3):223-30. PubMed ID: 14668200
[TBL] [Abstract][Full Text] [Related]
14. FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.
Santa María L; Aliaga S; Faundes V; Morales P; Pugin Á; Curotto B; Soto P; Peña MI; Salas I; Alliende MA
Genet Res (Camb); 2016 Jun; 98():e11. PubMed ID: 27350105
[TBL] [Abstract][Full Text] [Related]
15. Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males.
Biancalana V; Taine L; Bouix JC; Finck S; Chauvin A; De Verneuil H; Knight SJ; Stoll C; Lacombe D; Mandel JL
Am J Hum Genet; 1996 Oct; 59(4):847-54. PubMed ID: 8808600
[TBL] [Abstract][Full Text] [Related]
16. Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE.
Abrams MT; Doheny KF; Mazzocco MM; Knight SJ; Baumgardner TL; Freund LS; Davies KE; Reiss AL
Am J Med Genet; 1997 Feb; 74(1):73-81. PubMed ID: 9034011
[TBL] [Abstract][Full Text] [Related]
17. The influence of expanded unmethylated alleles for FRAXA/FRAXE loci in the intellectual performance among Brazilian mentally impaired males.
Barros Santos C; Gonçalves Pimentel MM
Int J Mol Med; 2003 Sep; 12(3):385-9. PubMed ID: 12883656
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of the FMR1 and FMR2 mutations among preschool children with language delay.
Mazzocco MM; Myers GF; Hamner JL; Panoscha R; Shapiro BK; Reiss AL
J Pediatr; 1998 May; 132(5):795-801. PubMed ID: 9602188
[TBL] [Abstract][Full Text] [Related]
19. Fragile X syndrome with FMR1 and FMR2 deletion.
Moore SJ; Strain L; Cole GF; Miedzybrodzka Z; Kelly KF; Dean JC
J Med Genet; 1999 Jul; 36(7):565-6. PubMed ID: 10424820
[TBL] [Abstract][Full Text] [Related]
20. The FMR2 gene, FRAXE and non-specific X-linked mental retardation: clinical and molecular aspects.
Gecz J
Ann Hum Genet; 2000 Mar; 64(Pt 2):95-106. PubMed ID: 11246464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
